PUBLICATIONS
Selected publications
(by year)
Selected publications
(by year)
David B; Jacob W. V; Philip S. I; Joana B. P; Long X; Laura E. M. W; Paul A. Y; Sebastian P; Niklas M; Erik S; Ruben S; Olof S; Oskar H
Brain: A Journal of Neurology 2021;144(9):2771-2783
Franziska A; Joana B. P; Mite M; Malin F; Hanna J; Urban E; Eric W; Erika F
Journal of Parkinson’s Disease 2021;11(4):2057-2071
Olof L; Silke K; Johan S; Alejandra M; Joana B. P; Simona F. S; Lars-Olof W; Kaj B; Henrik Z; Anna Z; Eric W; Ingmar S
Neurobiology of Aging 2021;101():44938
24. Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
Joana B. P; Shorena J; Ruben S; Niklas M; Sebastian P; Charlotte E. T; Henrik Z; Erik S; Nicholas J. A; Kaj B; Oskar H
Brain: A Journal of Neurology 2021;144(11):3505-3516
25. Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects
Joana B. P; Shorena J; Erik S; Sebastian P; Danielle v; Jeffrey L. D; Niklas M; Oskar H
Brain: A Journal of Neurology 2021;144(9):2826-2836
26. Sex differences in CSF biomarkers for neurodegeneration and blood-brain barrier integrity
Tobias S; Kaj B; Henrik Z; Sara S; Alejandra M; Joana P; Olof L; Michelle M. M; Anna Z; Lina R; Eric W; Lars-Olof W; Ingmar S; Silke K
Alzheimer’s & Dementia (Amsterdam, Netherlands) 2021;13(1):e12141
27. Sex differences in off-target binding using tau positron emission tomography
Ruben S; Olof S; Antoine L; Tobey J. B; Sterling C. J; Joana B. P; Oskar H
NeuroImage. Clinical 2021;31():102708
28. Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
Wiesje P; Rik O; Ellen D; Olof S; Frederik B; Betty M. T; Joana B. P; Oskar H
Alzheimer’s Research & Therapy 2021;13(1):138
29. The Cognitive Connectome in Healthy Aging
Eloy G; Lissett G; Joana B. P; Juan Andres H; Eric W; Giovanni V; José B; Daniel F
Frontiers in Aging Neuroscience 2021;13():694254
Joana B. P; Shorena J; Rik O; Hlin K; Ann B; Niklas M; Erik S; Ruben S; Henrik Z; Kaj B; Oskar H
Brain: A Journal of Neurology 2021;144(1):310-324
Lucia B; Eric W; Joana B. P; Alzheimer’s Disease Neuroimaging Initiative
Neurobiology of Aging 2020;88():61-70
32. Correction to: Relevance of biomarkers across different neurodegenerative diseases
Alexander J. E; Ayesha K; Emma C; Matthew J. B; Federica C; Elisabeth H. T; Konstantin S; Tehmina B; Mehrsa J; Peter N. E. Y; William J; Stephen F. C; Tammaryn L; Lea T. G; Joana B. P; Niklas M; Nicholas J. A; Jörg H; Henrik Z; Michael S; Ross W. P
Alzheimer’s Research & Therapy 2020;12(1):71
33. Delayed correlations improve the reconstruction of the brain connectome
Mite M; Joana B. P; Giovanni V
PloS One 2020;15(2):e0228334
Konstantinos P; Daniel F; Joana B. P; Örjan S; Prashanthi V; Eric W
Aging 2020;12(13):12622-12647
36. Imaging biomarkers in neurodegeneration: current and future practices
Peter N. E. Y; Mar E; Emma C; Meera S; Helen B; Anne M; Ashwin V. V; Rikki L; Daniel J; Matthew J. B; Eimear M; David B; Antoinette O; Nick C. F; Joana B. P; William J; Stephen F. C; Ross W. P; Michael S
Alzheimer’s Research & Therapy 2020;12(1):49
Daniela E; Joana B. P; Vesna J; Bengt W; Per N; Dag A; Erika B
Journal of Alzheimer’s disease: JAD 2020;77(3):1143-1155
Joana B. P; Sara H; Mattis J; Michel J. G; Olof S; Erik S; Eric W; Danielle v; Oskar H
Neurobiology of Disease 2020;139():104831
Gustav M; Claes H; Joana B. P; Sebastian P; Oskar H; Danielle v; Eric W
NeuroImage. Clinical 2020;27():102310
40. Relevance of biomarkers across different neurodegenerative diseases
Alexander J. E; Ayesha K; Emma C; Matthew J. B; Federica C; Elisabeth H. T; Konstantin S; Tehmina B; Mehrsa J; Peter N. E. Y; William J; Stephen F. C; Tammaryn L; Lea T. G; Joana B. P; Niklas M; Nicholas J. A; Jörg H; Henrik Z; Michael S; Ross W. P
Alzheimer’s Research & Therapy 2020;12(1):56